http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Miki Koroku ),( Teppei Omori ),( Harutaka Kambayashi ),( Shun Murasugi ),( Tomoko Kuriyama ),( Yuichi Ikarashi ),( Maria Yonezawa ),( Ken Arimura ),( Kazunori Karasawa ),( Norio Hanafusa ),( Masatos 대한장연구학회 2022 Intestinal Research Vol.20 No.1
Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have both inflammatory bowel disease and COVID-19, immunosuppressive therapy is essentially not recommended, and the treatment options are limited. Even in the COVID-19 pandemic, adjuvant adsorptive granulocyte and monocyte apheresis may safely bring ulcerative colitis (UC) into remission by removing activated myeloid cells without the use of immunosuppressive therapy. Our patient was a 25-year-old Japanese male with UC and COVID-19. This is the first case report of the induction of UC remission with granulocyte and monocyte apheresis treatment for active UC associated with COVID-19. (Intest Res 2022;20:150-155)